IPRO is a national organization providing a full spectrum of healthcare assessment and improvement services that foster more efficient use of resources and enhance healthcare quality to achieve better patient outcomes. Founded in 1984, IPRO is highly regarded for the independence of its approach, the depth of its knowledge and experience, and the integrity of its programs. IPRO holds contracts with federal, state and local government agencies, as well as private-sector clients, in more than 33 states and the District of Columbia. A national not-for-profit organization, IPRO is headquartered in Lake Success, NY and has regional offices in Albany, NY, New Jersey, North Carolina, Connecticut.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CELLTRION PARTNERS WITH THE CANADIAN BIOTECH COMPANY, IPROGEN BIOTECH TO DEVELOP A SERIES OF NOVEL ADCS

Celltrion, Inc. | April 08, 2019

news image

INCHEON, South Korea & VANCOUVER, British Columbia--(BUSINESS WIRE)--Apr 7, 2019--On April 8, Celltrion (KRX:068270) and the Canada-based iProgen Biotech Inc. announced to agree to partner for the development of novel ADCs against validated antibody targets, including HER2 1 and CD20 2. The terms of the partnership agreement include: (1) Celltrion manufactures and supplies four recombinant antibodies to iProgen, among which two are HER2 and CD20 targeting, selected by Celltrion, and two addi...

Read More

MEDICAL

PEPTILOGICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE CLINICAL TRIAL OF PLG0206 IN PERIPROSTHETIC JOINT INFECTION

Peptilogics | January 11, 2022

news image

Peptilogics, a biotech company that engineers peptide therapeutics to radically improve the treatment landscape for patients with life-threatening diseases, announced that the U.S. Food and Drug Administration as accepted the company's Investigational New Drug Application for PLG0206 to treat periprosthetic joint infection allowing the Phase 1b study to proceed. Peptilogics will evaluate the safety and efficacy of PLG0206 in a Phase 1b open-label, dose-escalating study i...

Read More

MEDTECH

SALIPRO BIOTECH RECEIVES EUROPEAN PATENT FOR ANTIGEN PRODUCTION

Salipro Biotech | February 09, 2022

news image

Swedish biotech company Salipro Biotech AB announced that the European Patent Office has granted a further European Patent to the company, No. EP 3 043 814 B1 entitled "Antigen and method for production thereof", following the approval of the US-member of this patent family already in 2018 under US Patent 10,159,729 B2. The patents cover the composition-of-matter, methods and uses of the company's novel antigen technology, strengthening Salipro Biotech's proprietary platform te...

Read More

MEDICAL

SALIPRO BIOTECH OBTAINS GRANTED PATENTS IN THE UNITED STATES AND CHINA FOR DIRECT EXTRACTION OF MEMBRANE PROTEINS AND LIBRARY GENERATION

Salipro Biotech | September 08, 2022

news image

Salipro Biotech AB, a Swedish biotech company with a leading technology platform for the stabilization of membrane proteins for drug development, announced today that its patent entitled "Saposin lipoprotein particles and libraries from crude membranes" has been issued by both the U.S. Patent and Trademark Office and by the China National Intellectual Property Administration. The patents cover the company's novel method of direct extraction of membrane proteins from cells or crude ...

Read More
news image

CELLTRION PARTNERS WITH THE CANADIAN BIOTECH COMPANY, IPROGEN BIOTECH TO DEVELOP A SERIES OF NOVEL ADCS

Celltrion, Inc. | April 08, 2019

INCHEON, South Korea & VANCOUVER, British Columbia--(BUSINESS WIRE)--Apr 7, 2019--On April 8, Celltrion (KRX:068270) and the Canada-based iProgen Biotech Inc. announced to agree to partner for the development of novel ADCs against validated antibody targets, including HER2 1 and CD20 2. The terms of the partnership agreement include: (1) Celltrion manufactures and supplies four recombinant antibodies to iProgen, among which two are HER2 and CD20 targeting, selected by Celltrion, and two addi...

Read More
news image

MEDICAL

PEPTILOGICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE CLINICAL TRIAL OF PLG0206 IN PERIPROSTHETIC JOINT INFECTION

Peptilogics | January 11, 2022

Peptilogics, a biotech company that engineers peptide therapeutics to radically improve the treatment landscape for patients with life-threatening diseases, announced that the U.S. Food and Drug Administration as accepted the company's Investigational New Drug Application for PLG0206 to treat periprosthetic joint infection allowing the Phase 1b study to proceed. Peptilogics will evaluate the safety and efficacy of PLG0206 in a Phase 1b open-label, dose-escalating study i...

Read More
news image

MEDTECH

SALIPRO BIOTECH RECEIVES EUROPEAN PATENT FOR ANTIGEN PRODUCTION

Salipro Biotech | February 09, 2022

Swedish biotech company Salipro Biotech AB announced that the European Patent Office has granted a further European Patent to the company, No. EP 3 043 814 B1 entitled "Antigen and method for production thereof", following the approval of the US-member of this patent family already in 2018 under US Patent 10,159,729 B2. The patents cover the composition-of-matter, methods and uses of the company's novel antigen technology, strengthening Salipro Biotech's proprietary platform te...

Read More
news image

MEDICAL

SALIPRO BIOTECH OBTAINS GRANTED PATENTS IN THE UNITED STATES AND CHINA FOR DIRECT EXTRACTION OF MEMBRANE PROTEINS AND LIBRARY GENERATION

Salipro Biotech | September 08, 2022

Salipro Biotech AB, a Swedish biotech company with a leading technology platform for the stabilization of membrane proteins for drug development, announced today that its patent entitled "Saposin lipoprotein particles and libraries from crude membranes" has been issued by both the U.S. Patent and Trademark Office and by the China National Intellectual Property Administration. The patents cover the company's novel method of direct extraction of membrane proteins from cells or crude ...

Read More